170 related articles for article (PubMed ID: 29989641)
1. In situ fluorescence monitoring of diagnosis and treatment: a versatile nanoprobe combining tumor targeting based on MUC1 and controllable DOX release by telomerase.
Si H; Wang L; Li Q; Li X; Li L; Tang B
Chem Commun (Camb); 2018 Jul; 54(59):8277-8280. PubMed ID: 29989641
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging of telomerase and the enzyme activity-triggered drug release by using a conformation-switchable nanoprobe in cancerous cells.
Shi H; Gao T; Shi L; Chen T; Xiang Y; Li Y; Li G
Sci Rep; 2018 Nov; 8(1):16341. PubMed ID: 30397241
[TBL] [Abstract][Full Text] [Related]
3. Microenvironmental Control of MUC1 Aptamer-Guided Acid-Labile Nanoconjugate within Injectable Microporous Hydrogels.
Xu C; Han X; Jiang Y; Yuan S; Wu Z; Wu Z; Qi X
Bioconjug Chem; 2017 Oct; 28(10):2530-2537. PubMed ID: 28949511
[TBL] [Abstract][Full Text] [Related]
4. DNA Polymer Nanoparticles Programmed via Supersandwich Hybridization for Imaging and Therapy of Cancer Cells.
Li N; Xiang MH; Liu JW; Tang H; Jiang JH
Anal Chem; 2018 Nov; 90(21):12951-12958. PubMed ID: 30303006
[TBL] [Abstract][Full Text] [Related]
5. Structure-Switchable DNA Programmed Disassembly of Nanoparticles for Smart Size Tunability and Cancer-Specific Drug Release.
Ye W; Chen X; Li X; Liu Y; Jia F; Jin Q; Ji J
ACS Appl Mater Interfaces; 2020 May; 12(20):22560-22571. PubMed ID: 32338490
[TBL] [Abstract][Full Text] [Related]
6. Rational Design of Multifunctional Gold Nanoparticles via Host-Guest Interaction for Cancer-Targeted Therapy.
Chen WH; Lei Q; Luo GF; Jia HZ; Hong S; Liu YX; Cheng YJ; Zhang XZ
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17171-80. PubMed ID: 26192215
[TBL] [Abstract][Full Text] [Related]
7. Self-Assembled Upconversion Nanoparticle Clusters for NIR-controlled Drug Release and Synergistic Therapy after Conjugation with Gold Nanoparticles.
Cai H; Shen T; Kirillov AM; Zhang Y; Shan C; Li X; Liu W; Tang Y
Inorg Chem; 2017 May; 56(9):5295-5304. PubMed ID: 28402112
[TBL] [Abstract][Full Text] [Related]
8. Tumor-homing, size-tunable clustered nanoparticles for anticancer therapeutics.
Kim J; Lee YM; Kang Y; Kim WJ
ACS Nano; 2014 Sep; 8(9):9358-67. PubMed ID: 25184691
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-carboxymethyl xanthan gum capped gold nanoparticles: Microwave synthesis, characterization, and anti-cancer activity.
Alle M; G BR; Kim TH; Park SH; Lee SH; Kim JC
Carbohydr Polym; 2020 Feb; 229():115511. PubMed ID: 31826400
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional Bioconjugate for Cancer Cell-Targeted Theranostics.
Du W; Yuan Y; Wang L; Cui Y; Wang H; Xu H; Liang G
Bioconjug Chem; 2015 Dec; 26(12):2571-8. PubMed ID: 26580576
[TBL] [Abstract][Full Text] [Related]
11. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
12. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
[TBL] [Abstract][Full Text] [Related]
13. A One-Two-Three Multifunctional System for Enhanced Imaging and Detection of Intracellular MicroRNA and Chemogene Therapy.
Liu X; Wang X; Ye S; Li R; Li H
ACS Appl Mater Interfaces; 2021 Jun; 13(24):27825-27835. PubMed ID: 34124898
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of MUC1 aptamer-stabilized gold nanoclusters for cell-specific imaging.
Feng B; Xing Y; Lan J; Su Z; Wang F
Talanta; 2020 May; 212():120796. PubMed ID: 32113558
[TBL] [Abstract][Full Text] [Related]
15. Inorganic and Metal-Organic Nanocomposites for Cascade-Responsive Imaging and Photochemical Synergistic Effects.
Hu X; Zhu Z; Dong H; Zhu X; Zhu H; Ogawa K; Odani A; Koh K; Chen H
Inorg Chem; 2020 Apr; 59(7):4617-4625. PubMed ID: 32207928
[TBL] [Abstract][Full Text] [Related]
16. Intelligent Nanoprobe: Acid-Responsive Drug Release and In Situ Evaluation of Its Own Therapeutic Effect.
Yang Y; He Y; Deng Z; Li J; Huang J; Zhong S
Anal Chem; 2020 Sep; 92(18):12371-12378. PubMed ID: 32786256
[TBL] [Abstract][Full Text] [Related]
17. Ultrasmall gold-doxorubicin conjugates rapidly kill apoptosis-resistant cancer cells.
Zhang X; Chibli H; Mielke R; Nadeau J
Bioconjug Chem; 2011 Feb; 22(2):235-43. PubMed ID: 21189001
[TBL] [Abstract][Full Text] [Related]
18. Polyelectrolyte/Gold Nanoparticle Nanotubes Incorporating Doxorubicin-Loaded Liposomes.
Enomoto Y; Akiyama M; Morita Y; Komatsu T
Chem Asian J; 2021 Dec; 16(24):4057-4061. PubMed ID: 34664406
[TBL] [Abstract][Full Text] [Related]
19. Aptamer/Graphene Quantum Dots Nanocomposite Capped Fluorescent Mesoporous Silica Nanoparticles for Intracellular Drug Delivery and Real-Time Monitoring of Drug Release.
Zheng FF; Zhang PH; Xi Y; Chen JJ; Li LL; Zhu JJ
Anal Chem; 2015 Dec; 87(23):11739-45. PubMed ID: 26524192
[TBL] [Abstract][Full Text] [Related]
20. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles.
Li D; Zhang YT; Yu M; Guo J; Chaudhary D; Wang CC
Biomaterials; 2013 Oct; 34(32):7913-22. PubMed ID: 23886730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
